Investigating how lung premalignant lesions behave over time

Persistence and regression in lung premalignant lesions

NIH-funded research University of Colorado Denver · NIH-11045467

This study is looking at early changes in the lungs that could lead to cancer, especially in former smokers and lung cancer survivors, to find ways to prevent lung cancer by identifying which changes are more likely to get worse and which might get better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project IDNIH-11045467 on NIH RePORTER

What this research studies

This research focuses on understanding the behavior of lung premalignant lesions (PMLs) to better prevent lung cancer. It aims to identify molecular patterns that distinguish PMLs likely to progress to cancer from those that may regress. By targeting high-risk patients, particularly former smokers and lung cancer survivors, the study seeks to develop precision prevention strategies that could reduce the risk of lung cancer. The approach involves analyzing key mechanisms in persistent PMLs to inform targeted pharmacological interventions.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with lung premalignant lesions, particularly former smokers and lung cancer survivors.

Not a fit: Patients without lung premalignant lesions or those with advanced lung cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to effective prevention strategies that significantly lower the risk of lung cancer in high-risk patients.

How similar studies have performed: Previous research has shown promise in identifying molecular patterns in cancer prevention, suggesting that this approach could yield significant insights.

Where this research is happening

Aurora, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.